AXCELIS TECHNOLOGIES INC
Axcelis designs, manufactures and services ion implantation and other processing equipment used to fabricate semiconductor chips. It sells primarily to semiconductor chip manufacturers worldwide, including integrated electronics manufacturers and foundries. Its main product line is the Purion family of high energy, high current and medium current ion implanters; it also offers Ovation batch implanters and systems for power-device applications. Through its Customer Solutions & Innovation business, Axcelis provides aftermarket services and products, including used tools, spare parts, equipment upgrades, maintenance, customer training and support over the equipment lifecycle. It makes money from equipment sales and aftermarket products and services. Ion implantation represented 98.2% of revenue in 2025, with the remainder derived from aftermarket sales associated with other legacy processing systems. Axcelis is headquartered in Beverly, Massachusetts.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $ACLS in the last 30 days.
See all $ACLS insider activity →B. Riley Securities kept Axcelis Technologies at Buy but reduced its price target to $140 from $165, a 15.2% cut. The new target suggests a 55.6% upside from the Nov 5 close of $90.
Axcelis Technologies reported Q3 2026 revenue of $238M, EPS of $1.26, and bookings of $222M, driven by demand recovery. The company expects growth in 2027 across memory, power, and other key markets, with Q4 revenue guidance of ~$275M.
Axcelis (ACLS) and Veeco (VECO) delayed their $4.4B merger to Q1 2027, awaiting regulatory approvals. NetApp (NTAP) completed its acquisition of PEAK:AIO to expand AI storage. Bilt (BILT) acquired LAVA for $300M, adding sports loyalty tech. RWS (RWS) completed its £40.2M acquisition of Acolad. Seequent, a Bentley Systems (BSY) subsidiary, acquired Eliis for AI seismic software.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning ACLS (AXCELIS TECHNOLOGIES INC). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent ACLS coverage spans financial news, earnings and mergers & acquisitions.
B. Riley Securities kept Axcelis Technologies at Buy but reduced its price target to $140 from $165, a 15.2% cut. The new target suggests a 55.6% upside from the Nov 5 close of $90.
Earnings beat and strong guidance suggest upside.
Deal delay and regulatory re-clearance extend uncertainty on closing timing and integration expectations.
The extended timeline may reduce near-term uncertainty for Axcelis, supporting its share price.
New CFO appointment may be viewed as a positive leadership change.
AlphAI scores every news story that mentions ACLS with an AI model for sentiment and relevance, and aggregates insider trades from AXCELIS TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
B. Riley Securities kept Axcelis Technologies at Buy but reduced its price target to $140 from $165, a 15.2% cut. The new target suggests a 55.6% upside from the Nov 5 close of $90.
Axcelis Technologies reported Q3 2026 revenue of $238M, EPS of $1.26, and bookings of $222M, driven by demand recovery. The company expects growth in 2027 across memory, power, and other key markets, with Q4 revenue guidance of ~$275M.
Axcelis (ACLS) and Veeco (VECO) delayed their $4.4B merger to Q1 2027, awaiting regulatory approvals. NetApp (NTAP) completed its acquisition of PEAK:AIO to expand AI storage. Bilt (BILT) acquired LAVA for $300M, adding sports loyalty tech. RWS (RWS) completed its £40.2M acquisition of Acolad. Seequent, a Bentley Systems (BSY) subsidiary, acquired Eliis for AI seismic software.
Axcelis Technologies (ACLS) and Veeco Instruments (VECO) announced their merger is expected to close by Q1 2027, pending regulatory approvals. The deal requires SAMR and HSR Act clearance. Each Veeco share will convert into 0.3575 Axcelis shares. Both companies are semiconductor equipment manufacturers.
Axcelis Technologies (ACLS) named Jeroen Delsman as its new CFO, effective November 12, 2026. David Ryzhik, interim CFO, will transition to a senior role.
AXCELIS TECHNOLOGIES INC (ACLS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Axcelis Technologies Names Jeroen Delsman as Executive Vice President and Chief Financial Officer BEVERLY, Mass., October 27, 2026 – Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, t
Axcelis Technologies (Nasdaq: ACLS) will release its Q3 2026 financial results on November 5, 2026, before market open. A conference call to discuss the results is scheduled for 8:30 a.m. ET the same day, accessible via webcast on the company's website. Axcelis is a supplier of ion implantation solutions for the semiconductor industry.
Axcelis (ACLS) plans to build a 200,000 sq. ft. manufacturing facility in Pyeongtaek, Korea, with production starting in late 2028. The company's CEO and local officials celebrated the groundbreaking, highlighting its significance for Axcelis' growth and the semiconductor industry.
Zacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.
Axcelis Technologies (ACLS) reported $839M revenue in 2025, with $570M in cash and minimal debt. It announced a $35M investment in a new ion implantation factory in Korea, expected to start production in late 2028. Q2 2026 revenue rose, but EPS fell to $0.75 from $0.98, with gross margin slipping to 42.4%. The company expects revenue growth in 2026-2027, guided at $230M for Q3. Hedge funds increased holdings, while short interest remains at 6.70%.
